BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20339101)

  • 1. Glycaemic control with insulin prevents the reduced renal dopamine D1 receptor expression and function in streptozotocin-induced diabetes.
    Moreira-Rodrigues M; Quelhas-Santos J; Serrão P; Fernandes-Cerqueira C; Sampaio-Maia B; Pestana M
    Nephrol Dial Transplant; 2010 Sep; 25(9):2945-53. PubMed ID: 20339101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective renal dopamine D1 receptor function contributes to hyperinsulinemia-mediated hypertension.
    Ahmad Banday A; Lokhandwala MF
    Clin Exp Hypertens; 2006 Nov; 28(8):695-705. PubMed ID: 17132536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats.
    Marwaha A; Banday AA; Lokhandwala MF
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F451-7. PubMed ID: 14612382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats.
    Nordquist L; Shimada K; Ishii T; Furuya DT; Kamikawa A; Kimura K
    Diabetes Metab Res Rev; 2010 Mar; 26(3):193-9. PubMed ID: 20225182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine receptors modulate the expression of insulin receptor, IGF-1 and GLUT-3 in diabetic rats: effect of pyridoxine treatment.
    Anitha M; Abraham PM; Paulose CS
    Eur J Pharmacol; 2012 Dec; 696(1-3):54-61. PubMed ID: 23001013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes.
    Lindsay RM; Jamieson NS; Walker SA; McGuigan CC; Smith W; Baird JD
    Diabetologia; 1998 May; 41(5):516-23. PubMed ID: 9628267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptozotocin induction of diabetes in rats leads to increased insulin-like growth factor-II/mannose-6-phosphate receptor mRNA expression in kidney but not in lung or heart.
    Kiess W; Hoeflich A; Yang Y; Groenbaek H; Flyvbjerg A
    Growth Regul; 1996 Jun; 6(2):66-72. PubMed ID: 8781982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
    Liu IM; Tzeng TF; Liou SS; Chang CJ
    J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
    Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of insulin therapy on biomechanical deterioration of bone in streptozotocin (STZ)-induced type 1 diabetes mellitus in rats.
    Erdal N; Gürgül S; Demirel C; Yildiz A
    Diabetes Res Clin Pract; 2012 Sep; 97(3):461-7. PubMed ID: 22483749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
    Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice.
    Kim MJ; Kim HK
    Life Sci; 2006 Nov; 79(24):2288-92. PubMed ID: 16945392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways.
    Manna P; Sinha M; Sil PC
    Toxicology; 2009 Mar; 257(1-2):53-63. PubMed ID: 19133311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of improved glycaemic control with chlorpropamide on microvascular reactivity and nitric oxide synthase activity in diabetic rats.
    Sartoretto JL; Santos RA; Scavone C; Tostes RC; Nigro D; Carvalho MH; Cuman RK; Fortes ZB
    J Pharm Pharmacol; 2007 Aug; 59(8):1117-23. PubMed ID: 17725854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasma glucose lowering action of tetrandrine in streptozotocin-induced diabetic rats.
    Chen WC; Hayakawa S; Yamamoto T; Huang LW; Liu IM; Cheng JT
    J Pharm Pharmacol; 2004 May; 56(5):643-8. PubMed ID: 15142342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic intrarenal insulin replacement reverses diabetes mellitus-induced natriuresis and diuresis.
    Manhiani MM; Duggan AD; Wilson H; Brands MW
    Hypertension; 2012 Feb; 59(2):421-30. PubMed ID: 22215718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term type 1 diabetes on renal sodium and water transporters in rats.
    Vidotti DB; Arnoni CP; Maquigussa E; Boim MA
    Am J Nephrol; 2008; 28(1):107-14. PubMed ID: 17943018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of cyclooxygenase 2 and prostagladin E(2) in the effects of insulin on gastric emptying in male rats.
    Huang W-; Hung C-; Chen M-; Wang J-; Doong M-; Wang C-; Hung C-; Wang PS
    J Physiol Pharmacol; 2009 Sep; 60(3):109-18. PubMed ID: 19826189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of impaired glucose uptake on postexercise glycogen repletion in skeletal muscles of insulin-treated streptozotocin-diabetic fasted rats.
    Ferreira LD; Xu D; Palmer TN; Fournier PA
    Metabolism; 2005 Nov; 54(11):1420-7. PubMed ID: 16253628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats.
    Umrani DN; Banday AA; Hussain T; Lokhandwala MF
    Hypertension; 2002 Dec; 40(6):880-5. PubMed ID: 12468573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.